Putnam Investments LLC Neurocrine Biosciences Inc Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Putnam Investments LLC holds 28,436 shares of NBIX stock, worth $3.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,436
Previous 29,235
2.73%
Holding current value
$3.61 Million
Previous $3.29 Million
13.93%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding NBIX
# of Institutions
625Shares Held
94.7MCall Options Held
642KPut Options Held
288K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.28 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$585 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$313 Million0.6% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.9MShares$241 Million4.37% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...